Sartorius Stedim Biotech S.A.
SDMHF
$192.00
$0.500.26%
OTC PK
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | 12.24% | 11.21% | 8.23% | 5.25% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 12.24% | 11.21% | 8.23% | 5.25% | |
| Cost of Revenue | 14.30% | 5.50% | 5.08% | -4.94% | |
| Gross Profit | 9.41% | 18.66% | 11.89% | 23.45% | |
| SG&A Expenses | 6.72% | 11.24% | 0.56% | 1.09% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -213.16% | 108.38% | 181.72% | 91.70% | |
| Total Operating Expenses | 8.90% | 7.90% | 5.11% | 9.22% | |
| Operating Income | 31.66% | 30.29% | 23.96% | -13.11% | |
| Income Before Tax | 107.46% | 49.14% | 44.53% | -31.13% | |
| Income Tax Expenses | 716.81% | 50.63% | 44.68% | -131.45% | |
| Earnings from Continuing Operations | 11.33% | 48.62% | 44.48% | 9.67% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | 115.60% | -- | 121.55% | 50.49% | |
| Net Income | 13.28% | 51.74% | 47.13% | 11.76% | |
| EBIT | 31.66% | 30.29% | 23.96% | -13.11% | |
| EBITDA | 23.72% | 21.95% | 17.45% | -12.67% | |
| EPS Basic | 13.69% | 45.50% | 47.09% | 6.13% | |
| Normalized Basic EPS | 36.92% | 46.61% | -- | 2,588.00% | |
| EPS Diluted | 13.69% | 45.50% | 47.09% | 6.13% | |
| Normalized Diluted EPS | 36.92% | 46.61% | -- | 2,588.00% | |
| Average Basic Shares Outstanding | -0.37% | 4.28% | 0.03% | 5.30% | |
| Average Diluted Shares Outstanding | -0.37% | 4.28% | 0.03% | 5.30% | |
| Dividend Per Share | 9.20% | -- | -- | -0.98% | |
| Payout Ratio | -- | -0.31% | -- | -- | |